Literature DB >> 7782426

Isolated polycystic morphology in ovum donors predicts response to ovarian stimulation.

I L Wong1, R S Morris, R A Lobo, R J Paulson, M V Sauer.   

Abstract

The isolated finding of polycystic-appearing ovaries on ultrasound examination of normal women is not uncommon. The purpose of this study was to determine the clinical significance of polycystic ovaries in a population of healthy, non-hirsute, fertile women preparing to undergo ovarian stimulation. We evaluated whether the finding of polycystic ovaries in oocyte donors predicts a different response to ovarian stimulation when compared to donors with normal-appearing ovaries. Furthermore, we examined whether oocytes from polycystic ovaries had the same capacity for fertilization and development as those retrieved from normal ovaries. In all, 11 donors with polycystic-appearing ovaries were compared prospectively to 13 donors with normal-appearing ovaries who were undergoing ovarian stimulation during the same time interval. The two groups were similar in age and baseline androgen concentrations. Significantly more oocytes were produced by the polycystic group for the amount of human menopausal gonadotrophin (HMG) administered (P < 0.05). In addition, all previous cycles completed by these 24 donors were compared (polycystic group: total of 31 cycles; normal group: total of 37 cycles). The donors with polycystic ovaries required less HMG to obtain optimal stimulation (P < 0.05), attained a greater peak oestradiol concentration (P < 0.05), produced a greater number of follicles (P < 0.05) and oocytes (P < 0.01) and a higher percentage of mature oocytes (P < 0.05). Furthermore, they achieved a higher peak oestradiol/HMG (P < 0.01) and oocytes/HMG ratio (P < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7782426     DOI: 10.1093/oxfordjournals.humrep.a135982

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  5 in total

1.  Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women.

Authors:  F Cano; J A García-Velasco; A Millet; J Remohí; C Simón; A Pellicer
Journal:  J Assist Reprod Genet       Date:  1997-05       Impact factor: 3.412

2.  The clinical ramifications of polycystic ovarian morphology in oocyte donors.

Authors:  M Cho; G Ambartsumyan; H Danzer; K Brennan; M Surrey
Journal:  J Assist Reprod Genet       Date:  2013-01-05       Impact factor: 3.412

Review 3.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.

Authors:  Mark O Goodarzi; Daniel A Dumesic; Gregorio Chazenbalk; Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

4.  Pregnancy outcome and follow-up of offspring of donor oocytes recipient from PCOS patients.

Authors:  Yan Jiang; Jing-Chuan Yuan; Ge Song; Xu-Hui Zhang; Sui-Bing Miao; Xiao-Hua Wu
Journal:  BMC Pregnancy Childbirth       Date:  2022-10-19       Impact factor: 3.105

5.  Are Patients with Polycystic Ovarian Syndrome Ideal Candidates for Oocyte Donation?

Authors:  George Queiroz Vaz; Alessandra Viviane Evangelista; Cassio Alessandro Paganoti Sartorio; Maria Cecilia Almeida Cardoso; Maria Cecilia Erthal; Paulo Gallo; Marco Aurelio Pinho Oliveira
Journal:  Biomed Res Int       Date:  2016-04-12       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.